| Patents for C07C 391 - Compounds containing selenium (659) | 
|---|
| 10/26/1999 | US5973009 Antioxidant and cytoprotecting activity | 
| 10/07/1999 | WO1999050317A1 A solid support based on selenium useful in solid phase synthesis | 
| 10/07/1999 | WO1999050239A2 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same | 
| 10/06/1999 | EP0946504A1 Compounds useful for perhalogenoalkylation, reagent for implementing these compounds and synthesis method for obtaining these compounds | 
| 08/31/1999 | US5945408 Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors | 
| 08/26/1999 | WO1998022435A9 Compounds useful for perhalogenoalkylation, reagent for implementing these compounds and synthesis method for obtaining these compounds | 
| 07/22/1999 | WO1999036384A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors | 
| 07/22/1999 | CA2317942A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors | 
| 06/22/1999 | US5914418 Polymerization inhibitor for acrylic-functional silanes | 
| 06/02/1999 | CN1218043A Preparation and use of selenium substituted chromium methionine | 
| 06/01/1999 | US5908741 Photographic silver halide material | 
| 04/21/1999 | EP0692976B1 Chelating agents of the type xn 1?s 1?o 1? for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy | 
| 04/08/1999 | WO1999010322B1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same | 
| 03/04/1999 | WO1999010322A1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same | 
| 02/17/1999 | EP0896972A1 Selenized transparent optical material | 
| 12/23/1998 | EP0885188A1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors | 
| 08/27/1998 | WO1998037117A1 Selenized transparent optical material | 
| 07/08/1998 | EP0572517B1 Catalytic process for converting hydrocarbonaceous feeds, particularly lower alkanes to esters, alcohols, and optionally to hydrocarbons | 
| 07/01/1998 | EP0850924A1 Aromatic diselenides and selenosulphides for use as antioxidant agents | 
| 05/28/1998 | WO1998022435A1 Compounds useful for perhalogenoalkylation, reagent for implementing these compounds and synthesis method for obtaining these compounds | 
| 05/26/1998 | US5756359 Medical diagnosis; mixture of periodate compound and complexing agent | 
| 05/13/1998 | EP0840604A1 Non-beta-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof | 
| 04/15/1998 | CN1179148A Reagent, compound and method for nucleophile perfluoroalkylation, and resulting derivatives | 
| 04/08/1998 | EP0688313B1 Ligands and metal complexes thereof | 
| 01/06/1998 | US5705528 Farnesyl derivatives and pharmaceutical compositions containing them | 
| 12/10/1997 | EP0810993A1 Reagent, compound and method for nucleophile perfluoroalkylation, and resulting derivatives | 
| 12/03/1997 | CN1166823A Liquid crystal compounds having perfluoroether terminal portions | 
| 11/04/1997 | US5683656 Decreased interference redox detection device | 
| 10/21/1997 | US5679695 Aryl and heteroaryl compounds having anti-retrovirus activity | 
| 10/01/1997 | CN1035997C Ligands and metal complexes thereof | 
| 09/12/1997 | WO1997032844A1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors | 
| 09/03/1997 | EP0792255A1 Liquid crystal compounds having perfluoroether terminal portions | 
| 09/02/1997 | US5663307 Useful in diagnostic and therapeutic methods | 
| 09/02/1997 | US5663164 1-dethia-2-thia-cephalosporanic acids | 
| 07/29/1997 | US5651954 Method of using hydrazone containing ligands and metal complexes thereof | 
| 04/02/1997 | EP0622076B1 Inhibitor for restenosis after percutaneous coronary arterioplasty | 
| 03/19/1997 | EP0763017A1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors | 
| 03/06/1997 | DE19532058A1 Photographic silver halogenide material stabilised with selenium cpd. | 
| 02/06/1997 | WO1997003663A1 NON-β-OXIDIZABLE FATTY ACID ANALOGUES, THEIR USES AS THERAPEUTIC ACTIVE MEDICAMENTS, AND PREPARATION THEREOF | 
| 02/06/1997 | CA2226871A1 Non-.beta.-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof | 
| 01/08/1997 | EP0751930A1 Amidino derivatives useful as nitric oxide synthase inhibitors | 
| 01/01/1997 | CN1139103A Process for synthesis of hydrocarbon compounds which are fluorinated on carbon of alkyl chain | 
| 09/04/1996 | EP0729930A1 Process for the synthesis of hydrocarbons fluorinated on a carbon of an alkyl chain | 
| 09/04/1996 | EP0729354A1 Farnesyl derivatives and pharmaceutical compositions containing them | 
| 08/29/1996 | WO1996026185A1 Reagent, compound and method for nucleophile perfluoroalkylation, and resulting derivatives | 
| 08/29/1996 | CA2170566A1 Process for synthesizing fluorinated hydrocarbons on a carbon of an alkyl chain | 
| 08/28/1996 | EP0728843A1 Interference-free redox detection system | 
| 08/24/1996 | CA2170110A1 Decreased interference redox detection system | 
| 06/18/1996 | US5527829 HIV protease inhibitors | 
| 05/23/1996 | WO1996015092A1 Liquid crystal compounds having perfluoroether terminal portions | 
| 05/23/1996 | CA2205170A1 Liquid crystal compounds having perfluoroether terminal portions | 
| 05/08/1996 | CN1122132A Ligands and metal complexes thereof | 
| 01/31/1996 | EP0606320B1 Preparation of dialkyl tellurium and dialkyl selenium | 
| 01/24/1996 | EP0692976A1 Chelating agents of the type xn 1?s 1?o 1? for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy | 
| 01/10/1996 | EP0447544B1 Novel onium salts and the use thereof as photoinitiators | 
| 01/09/1996 | US5482650 Liquid crystal compounds having perfluoroether terminal portions | 
| 01/02/1996 | US5480888 1,2-benzoisoselenazol-3-(2h)-(thi)one derivatives | 
| 12/27/1995 | EP0688313A1 Ligands and metal complexes thereof | 
| 11/30/1995 | WO1995032185A1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors | 
| 11/30/1995 | CA2190472A1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors | 
| 09/28/1995 | WO1995025717A1 Amidino derivatives useful as nitric oxide synthase inhibitors | 
| 09/12/1995 | US5449844 Intermediates for preparing vitamins A and E and carotenoids | 
| 08/15/1995 | US5442112 Reacting sodium chalcogenide with alkyl halide in two phase system of water and immiscible organic solvent using phase transfer catalyst, separating product | 
| 08/01/1995 | US5437812 Liquid crystal compounds having perfluoroether terminal portions | 
| 07/20/1995 | WO1995019338A1 Ligands and metal complexes thereof | 
| 07/20/1995 | CA2156605A1 Ligands and metal complexes thereof | 
| 05/18/1995 | WO1995013059A1 Farnesyl derivatives and pharmaceutical compositions containing them | 
| 02/15/1995 | EP0638112A1 Liquid crystal compounds having perfluoroether terminal portions | 
| 12/07/1994 | EP0626943A1 Bistriazenes as chemotherapeutic agents | 
| 11/02/1994 | EP0622076A1 Inhibitor for restenosis after percutaneous coronary arterioplasty | 
| 10/13/1994 | WO1994022497A1 Chelating agents of the type xn1s1o1 for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy | 
| 10/13/1994 | CA2156620A1 Chelating agents of the type xn1s1o for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy | 
| 09/08/1994 | DE4306556A1 Process for the preparation of organothiocyanates and -selenocyanates | 
| 07/27/1994 | EP0478590B1 Method for preparation of organo-tellurium and selenium compounds | 
| 07/13/1994 | EP0428706B1 Perfluorovinyl compounds | 
| 06/14/1994 | US5321138 Phenyl selenide derivatives | 
| 04/26/1994 | US5306855 Oxidative conversion to oxy-esters; conversion to alcohol intermediate; catalysis | 
| 02/15/1994 | CA1327047C Complexes of tellurium and selenium derivatives | 
| 12/08/1993 | EP0572517A1 Catalytic process for converting hydrocarbonaceous feeds, particularly lower alkanes to esters, alcohols, and optionally to hydrocarbons | 
| 11/16/1993 | US5262082 Ferroelectric liquid crystal compounds having perfluoroether terminal portions | 
| 11/11/1993 | WO1993022396A1 Liquid crystal compounds having perfluoroether terminal portions | 
| 11/11/1993 | CA2133652A1 Liquid crystal compounds having prefluoroether terminal portions | 
| 09/21/1993 | US5246951 Nonsteroidal antiinflammatory agents | 
| 08/24/1993 | US5238807 Silver halide photographic material | 
| 08/24/1993 | CA1321584C Process for the preparation of diarylsulfides or diaryselenides | 
| 08/24/1993 | CA1321545C Pharmaceutical compositions having antineoplastic activity | 
| 08/18/1993 | EP0391955B1 Method for preparation of dialkyl tellurium and dialkyl selenium | 
| 08/11/1993 | EP0554377A1 Aryl and heteroaryl compounds having anti-retrovirus activity | 
| 08/03/1993 | US5233113 Treatment with oxidizer, strong acid, oxidation catalyst gives esters of strong acid | 
| 07/22/1993 | WO1993013762A1 Inhibitor for restenosis after percutaneous coronary arterioplasty | 
| 06/02/1993 | EP0544588A1 Intermediates for the preparation of vitamin A and E and of carotenoids | 
| 05/29/1993 | CA2084046A1 Intermediates for the preparation of vitamin a and e and of carotenoids | 
| 05/27/1993 | WO1993010086A1 Process for preparing n-(arylsulphonyl)-carbamide acid derivates and intermediates useful for carrying out this process | 
| 05/13/1993 | WO1993009089A1 Bistriazenes as chemotherapeutic agents | 
| 04/15/1993 | WO1993007117A1 Preparation of dialkyl tellurium and dialkyl selenium | 
| 04/15/1993 | CA2119367A1 Preparation of dialkyl tellurium and dialkyl selenium | 
| 04/13/1993 | US5202456 Anticarcinogenic agents; methylating transferase inhibitors; farnesyl or geranyl sulfur-, oxygen or selenium-containing derivatives | 
| 02/10/1993 | EP0390833B1 Method for purification of tellurium and selenium alkyls | 
| 01/19/1993 | US5180844 Chemical intermediates for prostaglandins | 
| 11/24/1992 | US5166428 Organo tellurium or organo selenium compounds formed by exchange |